Filing Flows › Cerenome (CNSY) › Q2 2025
Cerenome (CNSY) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Cerenome (CNSY) reported revenue of $1.4M for the second quarter 2025 (Q2 2025), +9% from a year earlier and +31% from the quarter before. Operating margin was -110.6%, net earnings $5.2M (370.6% of revenue).
Cerenome, Q2 2025: revenue $1.4M (+9% year over year), operating margin -110.6%, net earnings $5.2M, operating cash flow −$5.8M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4M | +31% | +9% |
| Operating profit | −$1.5M | — | — |
| Net earnings | $5.2M | — | — |
| Operating cash flow | −$5.8M | — | — |
What changed
Revenue was $1.4M in Q2 2025, up 9% year over year and up 31% from the previous quarter.
Operating costs exceeded revenue by $1.5M, an operating margin of -110.6%. Total costs fell 41% while revenue rose 9%. Net earnings were $5.2M. The effective tax rate was 0.0%. Non-operating items added $6.7M, 130% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$5.8M. Non-cash charges added back $77K of depreciation and amortization and $152K of share-based compensation. Working capital and other items used $11.2M. Capital expenditures of $7K exceeded it, leaving free cash flow of −$5.8M.
Questions
What was Cerenome's revenue in the second quarter 2025?
Cerenome (CNSY) reported revenue of $1.4M for the second quarter 2025 (Q2 2025), +9% from a year earlier and +31% from the quarter before.
Was Cerenome profitable in the second quarter 2025?
Operating loss was $1.5M (-110.6% of revenue) and net earnings $5.2M.
Source: Cerenome 10-Q on SEC EDGAR.